The Combination of Uric Acid and Hemoglobin Levels Predicts the Incident Risk of Ischemic Heart Disease More Than Uric Acid Alone in Non-Diabetic Koreans: A Longitudinal Study Using National Health Insurance Data

• Published in: Journal of personalized medicine Vol. 14; no. 1; p. 7
• Main Authors: Lee, Sung-Bum, Lee, Hui-Jeong, Ryu, Ha Eun, Park, Byoungjin, Jung, Dong-Hyuk
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01-01-2024
• Subjects: Alcohol use; Angina pectoris; Blood pressure; Body mass index; Cardiovascular disease; Cardiovascular diseases; Cholesterol; Diabetes; Diabetes mellitus; Disease susceptibility; Fasting; Glucose; Glycosylated hemoglobin; Heart diseases; Hemoglobin; Hypertension; Ischemia; Kidney diseases; Metabolic syndrome; Myocardial ischemia; National health insurance; Plasma; Rheumatism; Risk factors; Thromboembolism; Type 2 diabetes; Uric acid; Variance analysis; Womens health; South Korea; United States > US; ischemic heart disease; national health insurance data; uric acid; hemoglobin; Korea
• ISSN: 2075-4426; 2075-4426
• DOI: 10.3390/jpm14010007

Uric acid has been related to cardiovascular disease (CVD). Recently, slightly elevated hemoglobin (Hb) was also shown to be associated with CVD. We retrospectively investigated the joint effect of uric acid and elevated Hb by comparing normal-range uric acid alone on incident ischemic heart disease (IHD) risk in a large cohort of non-diabetic Korean adults using National Health Insurance data. We assessed 16,786 participants without diabetes (8595 men and 8191 women) using extensive cohort data. High Hb was defined as ≥16.4 g/dL in men and 13.8 g/dL in women (>75th percentile). We analyzed the data using two different methods. First, the participants were divided into quartiles according to uric acid levels. Second, subjects were also divided into quartiles: reference (group 1), high uric acid and normal Hb (group 2), normal uric acid and high Hb (group 3), and normal uric acid and high Hb (group 4). We evaluated hazard ratios (HRs) with 95% confidence intervals (CIs) for IHD using multivariate Cox regression analysis over a 50-month follow-up. During the follow-up, 345 (1.9%) participants developed IHD. In the analysis using both uric acid and Hb, compared with the reference group, the HRs for IHD were 1.37 (95% CI, 1.01-1.86) in the second group, 1.63 (95% CI, 1.21-2.21) in the third group, and 1.86 (95% CI, 1.30-2.67) in the fourth group after adjusting for IHD risk factors. Subsequently, patients with high uric acid are more likely to develop incident IHD than control patients. Moreover, we confirmed the joint effects of high uric acid and high hemoglobin on incident IHD. Awareness of these interactions is essential for clinicians. Risk factor management and screening for IHD are part of the routine management of patients with high uric acid and Hb.